Dishman Carbogen Amcis
Dishman Carbogen Amcis, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in India. Founded in 1983, the company has established itself as a leader in contract research and manufacturing services, with a strong presence in Europe, North America, and Asia. Specialising in custom synthesis, active pharmaceutical ingredients (APIs), and drug development services, Dishman Carbogen Amcis is recognised for its innovative approach and commitment to quality. The company’s state-of-the-art facilities and expertise in complex chemistry set it apart in a competitive market. With a focus on sustainability and regulatory compliance, Dishman Carbogen Amcis has achieved significant milestones, including successful collaborations with major pharmaceutical companies. Its dedication to excellence has solidified its position as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does Dishman Carbogen Amcis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dishman Carbogen Amcis's score of 19 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dishman Carbogen Amcis's reported carbon emissions
In 2023, Dishman Carbogen Amcis reported total carbon emissions of approximately 83,113,600 kg CO2e, comprising about 68,113,600 kg CO2e from Scope 1 and about 15,700,600 kg CO2e from Scope 2 emissions. This represents a slight increase in emissions compared to 2022, where total emissions were about 83,113,600 kg CO2e, with similar contributions from Scope 1 and Scope 2. For 2024, the company aims to reduce its emissions to approximately 75,829,920 kg CO2e, with a target of about 58,157,000 kg CO2e from Scope 1 and about 17,725,920 kg CO2e from Scope 2. This indicates a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. Dishman Carbogen Amcis has not established any formal climate pledges or science-based targets for emissions reduction. The company continues to monitor its emissions and seeks to improve its sustainability practices in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 48,975,800 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 17,489,600 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dishman Carbogen Amcis is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
